ArticlebioRxiv : the preprint server for biology2023
FGF9, a potent mitogen, is a new ligand for integrin αvβ3, and the FGF9 mutant defective in integrin binding acts as an antagonist.
Chih-Chieh Chang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.